Ampio Pharmaceuticals (AMPE) receives FDA acceptance of a questionnaire that it plans to use in...

|About: Ampio Pharmaceuticals, Inc. (AMPE)|By:, SA News Editor

Ampio Pharmaceuticals (AMPE) receives FDA acceptance of a questionnaire that it plans to use in a pivotal trial in the U.S. for its Zertane treatment for premature ejaculation (PE). The testing will cost less than $4M. (PR)